The Kennemer Healthy H(e/a)ART Study

Determinants of arterial stiffness in subjects with HIV infection receiving HAART.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23210

Enrollment

120

Registered

2006-04-25

Start date

2006-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV patients using HAART, in these patients we register pereferal arterial stiffness by measuring pulse wave velocity.

Interventions

Periferal arterial pulsewave velocity registration, non invasive. Additional bloodanalyses, taken from patient at time of routine perferal blood draw pre visit outpatient clinic.

Eligibility

Inclusion criteria

Inclusion criteria: Patients, male and female, 18 years and older, receiving or just started HAART therapie without cardiac arythmia.

Exclusion criteria

Exclusion criteria: Cardiac arythmia.

Design outcomes

Primary

Measure	Time frame
Increase in pulse wave velocity.	—

Secondary

Measure	Time frame
Increased velocity (thus increased stiffness) related to glucose, lipidspectrum and inflammation parameters?	—

Contacts

Public ContactJ.T. Dissel, van

Leids Universitair Medisch Centrum Postbus 9600

j.t.van_dissel@lumc.nl+31715262613

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)